Unresectable colorectal cancer liver metastases: retrospective review and survival analysis

Date 29 June 2016
Event ESMO World Congress on Gastrointestinal Cancer 2016
Session ESMO World Congress on Gastrointestinal Cancer 2016 - Abstracts book
Presenter L. Calera Urquizu
Citation Annals of Oncology (2016) 27 (2): 1-85. 10.1093/annonc/mdw199
Authors L. Calera Urquizu1, I. Pajares2, A. Cebollero2, C. Vallejo3, R. Jaso4, V. Alvarez1, I. Trueba5, V. Alija1, M. Comin Ana2, F. Rivera6
  • 1Hospital Sierrallana, Torrelavega, Spain, /
  • 2Hospital Universitario Miguel Servet, Zaragoza, Spain, /
  • 3HUMS (Zaragoza), Zaragoza, Spain, /
  • 4HUMS, Santander, Spain, /
  • 5Hospital Txagorritxu, Vitoria, Spain, /
  • 6Hospital Universitario Marqués de Valdecilla, Santander, Spain, /

Abstract

Colorectal cancer is the most common tumor and it is the second cause of dead by cancer in Spain. About 50% of patients develop liver metastases. The majority of patients have metastatic disease that is not suitable for curative resection.